Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Quintiles allies with Dako on diagnostic services

Quintiles allies with Dako on diagnostic services

2nd November 2010

Quintiles has announced a new alliance with life sciences company Dako in order to provide diagnostic services to pharmaceutical companies involved in drug development.

The companies are allying to offer a number of integrated drug-diagnostic development services and companion diagnostic products, in order to help facilitate the creation of new oncology therapies.

In addition, Dako will be producing new cancer diagnostic tests that will be conducted by Quintiles as part of the clinical validation process.

The first company to benefit from this new arrangement will be AstraZeneca, which will be assisted by Dako and Quintiles in the development of one of its lead oncology compounds.

Thomas Wollman, senior vice president at Quintiles Global Central Laboratories, said: "We can help physician investigators select the right patients for the right clinical trials, thereby accelerating the development of personalised oncology therapies for our customers."

In September 2010, Quintiles announced that it is allying with Huya Bioscience International to help bring a new cancer drug to the worldwide market.ADNFCR-8000103-ID-800211905-ADNFCR

We currently have 6 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.